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Abstract Spontaneous excitatory postsynaptic currents 
(sEPSC) through AMPA-type channels were recorded on 
cultured hippocampal pyramidal neurons by means of the 
whole-cell patch-clamp technique. The protein kinase C (PKC) 
agonist 4P-phorbol 12-myristate 13-acetate (4P-PMA) produced 
a long-lasting increase in sEPSC frequency not mimicked by the 
inactive analogue 4a -PM and blocked by the protein kinase 
inhibitor staurosporine. The 4P-PMA-induced change in sEPSC 
frequency occurred without detectable change in |Ca2+ |i. After 
treatment with the microtubule-disrupting agent colchicine, 4P-
PMA caused a small and transient increase in sEPSC frequency. 
It is concluded that colchicine affects the PKC-induced 
functional plasticity of nerve cells most likely by disturbing the 
axonal transport. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Amino acid neurotransmitters are packaged into small 
vesicles that can release their content into the synaptic cleft 
even in the absence of depolarization of the presynaptic mem-
brane. This leads to activation of postsynaptic receptors gen-
erating spontaneous excitatory (sEPSC) or inhibitory (sIPSC) 
postsynaptic currents. The mechanisms underlying this spon-
taneous quantal release are not elucidated. However, the 
sEPSC (or sIPSC) frequency can be modulated by different 
protein kinase (PK) activators. For instance, forskolin and 
phorbol esters, known as cAMP-dependent P K A and P K C 
activators, respectively, produce a long-lasting modulat ion 
of spontaneous transmitter release [1-5]. 
Microtubules are found in most cell types, including neu-
rons, and are thought to be involved in many physiological 
functions like the intracellular t ransport of vesicles and mito-
chondria [6,7]. The axonal t ransport can be blocked by the 
microtubule-depolymerizing agent colchicine [6,8]. The action 
of this plant alkaloid could impair the functional properties of 
nerve cells since, for instance, it inhibits the transport of 
amine storage vesicles in sympathetic nerves [9]. Thus, uncou-
pling the nerve terminals from its axon may effect the respon-
siveness of a neuronal cell to agents acting at a presynaptic 
site and modulating synaptic transmission. This hypothesis 
was tested on cultured rat hippocampal cells. The phorbol 
ester 4[3-PMA was used to produce a long-lasting increase 
in sEPSC frequency. This effect that occurred without detect-
able change in [Ca2 +] ; was strongly attenuated after colchicine 
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treatment. The inactive analogue P-lumicolchicine failed to 
mimick this effect showing that colchicine impairs the P K C -
induced synaptic plasticity of cultured hippocampal cells, 
most probably by blocking the axonal transport. 
2. Materials and methods 
2.1. Cell cultures 
Hippocampal cell cultures were prepared from 3- to 5-day-old 
Sprague-Dawley rats as described in detail elsewhere [10-12]. Briefly, 
the cell dissociation procedure consisted of a trypsin treatment (3.4 
mg/ml trypsin type XI+0.9 mg/ml DNase type IV) followed by a 
gentle mechanical trituration in a Ca2+-free Hanks' solution supple-
mented with 12 mM MgSC>4, 0.4 mg/ml DNase and 3 mg/ml bovine 
serum albumin. After centrifugation (2 times 80 Xg for 15 min) the 
dissociated cells were plated on poly-L-ornithine-coated coverslips in a 
small area confined by a cloning cylinder. Hippocampal cells were 
kept in a small volume ( = 160 u,l) of minimal essential medium sup-
plemented with 29.2 mg/ml glutamax, 6000 mg/1 glucose, 25 mg/1 
insulin, 100 mg/1 transferrin, 5 mg/1 gentamycin, and 10% fetal calf 
serum (FCS). Cells were maintained in a incubator at 37°C (6.5% 
CO2). To reduce astrocyte growth, cytosine (3-D-arabinofuranoside 
(3 |iM) was added at day 2. At that time 2% of B-27 supplement 
was then added to the culture medium and the FCS was reduced to 
5%. Some culture dishes were treated with colchicine (10 |iM) or fS-
lumicolchicine (10 uM) for 9-25 h prior to the electrophysiological 
experiments. 
2.2. Electrophysiology 
sEPSCs were recorded on hippocampal pyramidal cell bodies by 
means of the whole-cell configuration of the patch-clamp technique 
[13] with an EPC7 amplifier (List Electronics, Germany). Thick-wall 
glass pipettes (1.5-3.5 M£2) were filled with a solution containing (in 
mM): Cs-gluconate or CsF, 135; MgCl2, 2; EGTA, 10; HEPES, 10; 
Na2ATP, 2-5; GTP, 0.2 (pH 7.2). Throughout this study the cells 
were voltage-clamped at —50 mV and the sEPSCs were filtered at 
1-2 kHz and sampled on-line at 10 kHz on the hard disk of a micro-
computer driven by the CED software (version 6.0, Cambridge Elec-
tronics, UK) [14]. Cells were kept on the stage of an inverted micro-
scope and bathed with a medium consisting of (in mM): NaCl2, 135; 
KC1, 5; MgCl2, 2; CaCl2, 2 or 10; glucose, 30; HEPES, 10 (pH 7.4). 
Drug-containing solutions were added by a gravity-driven system per-
fusing the entire chamber. All the experiments were performed at 
room temperature. 
sEPSCs have been analyzed as described before [14] with a fully 
automated computer program written by Dr. A. Dityatev (University 
of Hamburg, Germany), based on the algorithm of Ankri et al. [15]. 
2.3. [Ca2+J[ measurements 
Changes in the intracellular concentration of Ca2+ ([Ca2+]i) were 
measured with the fluorescent probe Fluo-3. Hippocampal cells were 
incubated with 5-10 aM Fluo-3/AM for 30-50 min. The experiment 
procedures, carried out with a confocal Laser Scan Microscope 
(LSM410, Zeiss AG, Germany), have been explained in detail else-
where [12,14]. 
2.4. Materials 
Trypsin (type XI), cytosine (3-D-arabinofuranoside, the DNase (type 
IV), and bicuculline were purchased from Sigma Chemie AG (Buchs, 
Switzerland). 4p"-PMA was from Sigma (St. Louis, MO). The B-27 
supplement was from Gibco BRL (Life Technologies, Basel, Switzer-
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P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 1 3 5 - X 
222 A. BouronlFEBS Letters 404 (1997) 221-226 
land), the minimal essential medium was from Gibco BRL or Sigma 
Chemie AG (Buchs, Switzerland). TTX was from Calbiochem Bio-
chemicals (Lucern, Switzerland). CNQX was purchased from Tocris 
Cookson (St. Louis, MO), 4a-PMA from ICN Biomedicals (Meck-
enheim, Germany), and staurosporine from Fluka AG (Buchs, Swit-
zerland). Fluo-3 was from Molecular Probe (Leiden, The Nether-
lands), colchicine and P-lumicolchicine from Serva (Wallisellen, 
Switzerland). 
3. Results 
Throughout this study, measurements were done 9-15 days 
after the plating of the hippocampal cells. sEPSCs were re-
corded from an holding potential of —50 mV in the presence 
of 0.1-0.2 uM TTX or 100 uM CdCl2 to block propagated 
action potentials and evoked transmitter release. The sam-
pling of the sEPSCs started 2-3 min after the establishment 
of the whole-cell configuration. Postsynaptic currents were 
sampled for 3.1-6.2 s every minute for 5-7 min before the 
addition of 4a- or 4|3-PMA. 
Fig. 1A shows representative current traces of sEPSCs re-
corded in the presence of 100 uM Cd2+. The addition of the 
AMPA channel antagonist 6-cyano-nitroquinoxaline-2,3-di-
one (CNQX, 10 uM) reversibly blocked the sEPSCs. Under 
the experimental conditions (2 mM MgCl2 in the external and 
pipette solutions), the NMD A channels were completely in-
hibited. The addition of 100 nM 4(3-PMA increased the 
sEPSC frequency (Fig. IB). This effect could also be com-
pletely and reversibly inhibited by CNQX. Thus, the basal 
activity and the 4(3-PMA-induced increase of sEPSC fre-
quency are both mediated by CNQX-sensitive glutamate re-
ceptors. Fig. 1C shows the time-dependence of the 4P-PMA 
action. The sEPSC frequency increased rapidly after the addi-
tion of the PKC activator (Fig. 1C, ■) and could remain 
elevated for up to 90 min. This long-lasting change in sEPSC 
frequency was never observed with 4a-PMA (Fig. 1C, □, and 
Fig. IE). Ten minutes after its addition, 4J3-PMA produced a 
4-5-fold increase in sEPSC frequency (Fig. IE). This effect 
was blocked by the protein kinase inhibitor staurosporine. 
Similar effects of 4(3-PMA were observed when Na+ channels 
were inhibited with TTX (Fig. IE). 
4p-PMA did not affect the kinetic properties of sEPSCs. 
Mean rise times (10-90%) were 0.88±0.02 ms (n= 111) and 
0.90 ±0.02 ms (n = 442) (means ± SEM) in control and 40-
PMA-treated cells. Amplitude distribution histograms pre-
sented in Fig. ID illustrate the change in sEPSC frequency. 
They were constructed after sampling sEPSCs for 24.8 s in 
control and in 4p-PMA-containing solutions, respectively. 
sEPSC amplitudes were 12.3 ±0.5 pA («= 111) and 
14.3 ±0.4 pA {n-442) in control and 4P-PMA-treated cells. 
The inset shows amplitude distribution histograms from the 
same experiment but constructed with an equal number 
(«=111) of sEPSCs for each experimental condition. Both 
histograms are perfectly superimposable, indicating that 40-
PMA had no effect on the amplitude of sEPSCs. 
Taken together, these data show that 4P-PMA up-regulated 
the spontaneous release of glutamatergic synaptic vesicles in 
hippocampal pyramidal cells most probably by activating 
PKC. Furthermore, the increase in spontaneous transmitter 
release occurs even after the blockage of voltage-gated Ca2+ 
channels (i.e. in Cd2+ solution) or after preventing cell depol-
arization (i.e. in TTX solution). This eifet was without detect-
able change in the kinetic properties or amplitudes of the 
sEPSCs, indicating a presynaptic site of action of 4P-PMA 
[3,4,16]. 
Since the evoked release of neurotransmitters critically de-
pends on an influx of Ca2+ through voltage-gated Ca2+ chan-
nels [17,18], the role of the external and internal [Ca2+] on the 
4p-PMA-induced modulation of synaptic transmission has 
also been investigated. Experiments similar to the ones re-
ported in Fig. 1 were also carried out in the presence of 10 
mM external [Ca2+] (Fig. 2A) instead of 2 mM [Ca2+] (Fig. 1). 
In both cases 4P-PMA produced a ~ 4-fold increase in sEPSC 
frequency. If hippocampal cells were incubated with the cell 
permeant Ca2+-chelator BAPTA/AM (2 uM at 37°C for > 20 
min) the sEPSC frequency was increased to a similar extent by 
4P-PMA (Fig. 2A). This shows that 4P-PMA-induced modu-
lation of synaptic transmission was not affected by changes in 
[Ca2+]0 [4] and the PKC activator does not exert its action by 
an increase in basal [Ca2+];. This was further tested by meas-
uring [Ca2+]; with the fluorescent probe Fluo-3. The measure-
ments were done on cell bodies and on dendritic networks. A 
field stimulation (20 Hz, 1 ms pulse duration) increased 
[Ca2+]i in cell bodies (Fig. 2B) and dendrites (Fig. 2C, solid 
lines). The [Ca2+]i returned to basal levels after cessation of 
the stimulus. This stimulus-induced [Ca2+]i rise was com-
pletely and reversibly inhibited in the presence of TTX, 
Cd2+, and CNQX (Fig. 2B,C, dotted lines). 4P-PMA was 
then perfused together with these blockers. Under these con-
ditions the basal level of [Ca2+]; remained stable indicating 
that 4P-PMA does not increase [Ca2+]i (Fig. 2D,E). 
The plant alkaloid colchicine blocks axonal transport of 
vesicles [6,7,19]. Experiments were performed to assess the 
role of the microtubule-associated transport on the long-last-
ing 4P-PMA-induced change in sEPSC frequency. 
Hippocampal cells were incubated with colchicine (10 uM) 
or its inactive analogue P-lumicolchicine (10 uM) for 9-25 h. 
Colchicine-treated cells had the same morphology as P-lumi-
colchicine-treated cells. Cell capacitance values were 36.6 ± 4.6 
pF (n = 9) and 32.9 ± 3.2 pF (n = 3) in colchicine- and p-lumi-
colchicine-treated cells, respectively, indicating no change in 
cell size. Colchicine did not affect the basic exocytotic process 
because sEPSCs (Fig. 3A) could be observed even after a 24 h 
Fig. 1. 4|3-PMA increases the sEPSC frequency. Cultured hippocampal pyramidal cell bodies were voltage-clamped at —50 mV. The external 
medium contained 2 mM Ca2+ and 100 uM Cd2+. A: sEPSCs were reversibly blocked by CNQX (10 uM). B: 4p-PMA (100 nM) increased 
the sEPSC frequency. This effect was reversibly inhibited by CNQX (10 |xM). C: Time-dependence of 4|3-PMA action. The graph shows nor-
malized sEPSC frequencies before and during the addition of 4a- (□) or 4p-PMA (■). The drugs were added at time 0. D: Amplitude distribu-
tion histograms of sEPSCS sampled for 24.8 s before (solid line, n= 111 sEPSCs) and during 4|3-PMA application (dotted line, n-442 sEPSCs). 
The inset shows similar amplitude distribution histograms from the same experiment but with an equal number of sEPSCs (n= 111) for each 
group (control: solid line; 4|3-PMA: dotted line). The data reported in (A,B), (C) and (D) were collected from 3 different cells. E: The graph 
shows the change in sEPSC frequency, in Cd2+-containing solution, measured 10 min after the addition of the vehicle (0.01% DMSO, control), 
4P-PMA (100 nM), or 4a-PMA (100 nM). Some cells were pretreated with staurosporine (500-800 nM for 15-35 min, staur.) or TTX (100 
nM) before the addition of 4p-PMA. The number of cells tested is indicated above each bar (means ± SEM). *P<0.05, **P<0.01 vs. control. 
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treatment of cells with the plant alkaloid. Since colchicine 
treatment has been reported to affect ligand-gated ion channel 
properties expressed in Xenopus oocytes [20], the kinetic char-
acteristics of the sEPSCs were analyzed. The rise-times were 
1.1 ±0.02 ms (n=161) and 1.2±0.04 ms (n=161) in colchi-
cine- and p-lumicolchicine-treated cells, respectively. Ampli-
tude distribution histograms had comparable peaks (Fig. 
3A), indicating that the treatment did not affect postsynaptic 
receptor functions (19.2 ±1.2 pA ( K = 1 6 1 ) in colchicine- vs. 
17.7 ± 1.4 pA («= 161) in P-lumicolchicine-treated cells). 
When cultured cells were incubated for 16-25 h with 10 uM 
P-lumicolchicine and washed with a normal saline the external 
application of 100 nM 4p-PMA increased sEPSC frequency 
5.6 ± 1.5 fold (n - 3) in a time-dependent manner as illustrated 
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Fig. 2. Dependence of 4|3-PMA action on [Ca2+]. A: The graph shows the x-fold increase in sEPSC frequency measured 10 min after the addi-
tion of 4P-PMA (+) or its vehicle ( - ) . Cells were superfused with 10 mM [Ca2+]„. Cd2+ (100 uM) was used to block voltage-gated Ca2+ chan-
nels. Some cells were incubated at 37°C in the presence of the cell permeant Ca2+-chelator BAPTA/AM (2 itM). The number of cells tested is 
indicated above each bar (means ± SEM). B-D: [Ca2+]i signals were recorded by the means of the fluorescent dye Fluo-3. The cells were incu-
bated with 5-10 iiM of the membrane permeable Fluo-3/AM for 30-50 min. [Ca2+]j changes were measured in cell bodies (B,D) and in the 
dendritic network (C,E). Hippocampal cells were field stimulated at 20 Hz for 4-5 s (arrows) without (solid lines, B,C) or with 0.2 iiM TTX 
+ 100 itM Cd2+ +10 uM CNQX (dotted lines, B,C). D,E: When indicated (downward arrow) 4(3-PMA (100 nM) was added and continuously 
superfused in the presence of the Mockers (TTX, Cd2+, CNQX). D: Cell body. E: Dendrites. Similar results were obtained on 4 cells from 
3 cell cultures. ++P<0.01 vs. control (no added 4(3-PMA). 
A. BouronlFEBS Letters 404 (1997) 221-226 225 
■° Si c J -
Colchic ine 
A] 
*m*tom#u 
a] .IS] 
(3-Lumi colchic ine 
0 20 40 60 80 100 
amplitude of sEPSCs (pA) 
B 
4J3-PMA 
■ ■ . ' ■ 
■ 
■ 
■ 
■ 
■ 
■fl1 
0 10 
Time 
:■ 
0> 
© &> 
■ u 
20 
■ 
■ 
8 
6 
4 
2 
0 
(min) 
, 4 
1, 
Col. f 
30 
3 
i 
i-Lumi 
40 
4p-PMA 
I . I -■ 
■ 
■ 
■ 
■ ■ 
°Sca § B 
- ^ 
■ 
C 
I 1 h 
B 17 h 
0 10 20 30 
Time (min) 
40 
Fig. 3. The long-lasting increase in sEPSC frequency induced by 4p-
PMA is inhibited by colchicine. A: Amplitude distribution histo-
grams of sEPSCs recorded on cells pretreated with colchicine (10 
uM, 14 h, solid line) or with its inactive analogue p-lumicolchicine 
(10 uM, 17 h, dotted line). In the inset, sEPSCs measured after the 
indicated treatment are shown. Scale bars: 10 pA, 1 s. B: Time-de-
pendence of 4P-PMA action. p-Lumicolchicine-treated cells re-
sponded to 4p-PMA like non-treated cells (see Fig. 1). 4P-PMA was 
added at time 0. The plot in inset shows the x-fold increase in 
sEPSC frequency induced by 100 nM 4p-PMA on colchicine (Col.)-
and P-lumicolchicine (P-Lumi.)-treated cells. The number of cells 
tested is indicated above each bar. The external medium contained 
100 uM Cd2+ and 100 nM 4P-PMA. The cells were pretreated for 
9-24 h (Col.) and 16-25 h (p-Lumi) (means ± SEM). *P<0.05 vs. 
P-lumicolchicine. C: Cultured hippocampal cells were incubated 
with 10 uM colchicine for 1 (■) or 17 h (□). In the latter case, 4p-
PMA produced only a small and transient increase in sEPSC fre-
quency. 
in Fig. 3B. In the presence of colchicine, this effect was not 
only considerably reduced after a prolonged treatment of the 
cells (9-24 h, « = 4) but within 20-40 min the sEPSC fre-
quency returned to the level before 4P-PMA application. 
Thus, 4(3-PMA produced only a transient 2-fold change in 
sEPSC frequency (1.9 ±0.3 (« = 3); Fig. 3C, □) in colchicine-
treated cells. Short-time exposures (1-3 h) to colchicine failed 
to mimick this inhibitory effet (Fig. 3C, ■). 
4. Discussion 
The phorbol ester 4p-PMA produced a long-lasting increase 
in sEPSC frequency, most likely through activation of PKC 
[1,3-5]. A previous study showed that this effect requires an 
influx of Ca2+ through voltage-gated Ca2+ channels [16]. 
However, the experiments reported with the non-specific volt-
age-gated Ca2+ channel blocker Cd2+ (Fig. 1) do not support 
this notion. A similar conclusion was reached for the effect of 
the phorbol ester PBDu on sIPSCs [5]. The change in sEPSC 
frequency occurs in absence of [Ca2+]0 [4], in low and high 
[Ca2+]0, and in BAPTA/AM-loaded cells. Furthermore, 4(3-
PMA exerts its action without any detectable change in 
[Ca2+]i. These results show that phorbol esters can modulate 
synaptic transmission in a Ca2+-independent manner. In chro-
maffin cells 4|3-PMA increases the size of the pool of readily 
releasable vesicles [21]. This could explain the 4(3-PMA effects 
in the present study. 
The most striking result is the reduction of the 4p-PMA-
induced enhancement of sEPSC frequency after exposure to 
colchicine (Fig. 3). Short-term exposures to colchicine failed 
to produce this effect. Furthermore, P-lumicolchicine-treated 
cells responded to 4P-PMA like non-treated cells, indicating 
the specificity of the colchicine action. The data presented in 
Fig. 3 are not due to postsynaptic alterations for the following 
reasons: (1) kinetics and amplitude distribution histograms of 
sEPSCs were similar in P-lumicolchicine- and colchicine-
treated cells; and (2) micro tubules are sometimes found in 
the neck of dendritic spines but are absent from the bulb 
that is enriched in actin filaments [6,22]. Thus, the ability of 
colchicine to prevent the 4P-PMA-induced enhancement of 
sEPSC frequency is most likely a presynaptic effect. One pos-
sible explanation is a colchicine-induced disruption of the mi-
crotubule-network [19] and, thereby, a blockade of the axonal 
transport of vesicles [6,7]. The occurrence of sEPSCs indicates 
that the treatment did not block the exocytotic machinery. 
This is in agreement with recent work showing that colchicine 
does not affect the cycling of presynaptic vesicles stained with 
the styryl dye FM1-43 [23]. Colchicine-treated cells underwent 
normal activity-dependent exo/endocytotic cycles, indicating 
that colchicine treatment did not block the vesicle mobiliza-
tion at the release sites [23]. Thus, the effects reported in the 
present study may be the consequence of colchicine-induced 
changes that take place upstream of the nerve terminal. Pre-
synaptic proteins, synthetized in the cell body, migrate down 
the axon [24]. The colchicine-induced block of the axonal 
transport may have interrupted this flow, altering the nerve 
terminal content of newly synthetized proteins. Numerous cy-
toskeleton, cytosolic and presynaptic proteins can be phos-
phorylated by PKC. For instance, several endogenous PKC 
substrates are present in hippocampal synaptosomal prepara-
tions [25]. Then, the reduction of the 4p-PMA-induced in-
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crease in sEPSC frequency could be a consequence of a de-
creased level of PKCs and/or P K C substrates. 
The site of synaptic vesicle formation is not known. They 
can originate from the nerve terminal or the cell body, e.g. via 
the trans-Golgi network [24]. In the light of previous experi-
ments [21], it is tempting to speculate that the modest increase 
in sEPSC frequency produced by 4(3-PMA in colchicine-
treated cells is due to a reduced number of presynaptic 
vesicles. 
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